; (ii) in subparagraph (I), by inserting , through a standard operating procedure, after ensure ; (iii) by redesignating subparagraphs (H) through (K) as subparagraphs (I) through (L), respectively; and (iv) by inserting after subparagraph (G) the following: (H) utilize tools to enable the timely and accurate tracking of the contents of the stockpile throughout the deployment of such contents, including tracking of the location and geographic distribution and utilization of such contents; ; and (C) in paragraph (5)(B), in the matter preceding clause (i), by inserting , which may accompany the review required under paragraph (2), after Representatives a report ; (2) in subsection (c)(2)(C)— (A) by striking promptly ; and (B) by inserting , not later than 60 days after each such determination, ; (3) in subsection (f)(1), by striking $610,000,000 for each of fiscal years 2019 through 2021, and $750,000,000 for each of fiscal years 2022 and 2023 and inserting $965,000,000 for each of fiscal years 2024 through 2028 ; and (4) in subsection (g)(1), by striking 2019 through 2028 and inserting 2024 through 2033 . 207. Medical countermeasures for viral threats with pandemic potential Section 319L of the Public Health Service Act ( 42 U.S.C. 247d–7e ) is amended— (1) in subsection (c)(4)— (A) in subparagraph (D), by amending clause (iii) to read as follows: (iii) research to promote strategic initiatives, such as— (I) rapid diagnostics; (II) broad spectrum antimicrobials; (III) medical countermeasures for virus families that have significant potential to cause a pandemic, including such countermeasures that take either pathogen-specific or broad spectrum approaches; and (IV) technologies to improve the production and use of medical countermeasures, which may include vaccine-manufacturing technologies, dose-sparing technologies, efficacy-increasing technologies, platform technologies, technologies to administer countermeasures, and technologies to improve storage and transportation of countermeasures.